國立虎尾科技大學 |

Neuroendocrine Neoplasia Management = New Approaches for Diagnosis and Treatment /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Neuroendocrine Neoplasia Management/ edited by Giordano Beretta, Alfredo Berruti, Emilio Bombardieri, Nicola Fazio, Orlando Goletti.
其他題名:	New Approaches for Diagnosis and Treatment /
其他作者:	Goletti, Orlando.
面頁冊數:	XIV, 331 p. 52 illus., 48 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Endocrinology. -
電子資源:	https://doi.org/10.1007/978-3-030-72830-4
ISBN:	9783030728304

Neuroendocrine Neoplasia Management = New Approaches for Diagnosis and Treatment /
Neuroendocrine Neoplasia ManagementNew Approaches for Diagnosis and Treatment /[electronic resource] :edited by Giordano Beretta, Alfredo Berruti, Emilio Bombardieri, Nicola Fazio, Orlando Goletti. - 1st ed. 2021. - XIV, 331 p. 52 illus., 48 illus. in color.online resource.

Part-1: General. History of Neuroendocrine Neoplasia -- Epidemiology of neuroendocrine neoplasms. Part-2: Diagnosis. New concepts in patholog -- Molecular Biology of Neuroendocrine Tumors -- Circulating biochemical markers of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NENs) -- Advances in diagnostic imaging. Part-3: New Approaches for Treatment. Treatment of NET related symptoms -- New Surgical Strategies -- New approaches in medical therapies -- Loco-regional Therapies of NEN -- Radioreceptor therapy -- NETs of the lung -- Part-4: Treatment of NETs From Different Organ Origin. Gastric Neuroendocrine Tumors -- Treatment of Pancreatic Neurendocrine Tumors -- Treatment of intestinal NETs (including appendix) -- Treatment of NETs from rare origin -- Neuroendocrine Neoplasms with Peculiar Biology and Features: MEN1, MEN2A, MEN2B, MEN4, VHL, NF1. Part-5: NETs with Peculiar Biology and Feature. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasms ( Mi NEN) -- Merkel Cell Carcinoma -- Therapy in poorly differentiated neuroendocrine neoplasms (NEN G3) -- Conclusion:NENs management today looking at the future.

This book provides the most recent update on the management of neuroendocrine neoplasia (NEN), a term covering all tumors of various organs and/or with a particular histology, including MEN (multiple endocrine neoplasia) related tumors, MiNEN (mixed neuroendocrine-non-neuroendocrine neoplasms), NEC (neuroendocrine carcinoma) and Merkel’s carcinoma. NENs are heterogeneous in their biology, clinical presentation and prognosis, showing a great variability in aggressiveness and therapy response. As a result, their treatment is based on a large spectrum of options. The standard therapies are surgery in early disease, various loco-regional procedures in certain conditions and mostly of a palliative nature in metastatic disease. At present, thanks to our increased understanding of molecular signaling pathways, several pharmacological approaches can be used in patients with advanced NENs. Somatostatin analogs display both anti-tumor effects and symptom control. Novel peptide-radio-receptor treatment (PRRT) is used in patients with well differentiated tumors. The agents targeting angiogenesis and/or PI3K/AKT/mTOR pathway, alone or in combination with analogues, have provided encouraging results in advanced disease. The first part of the book focuses on the history, epidemiology and the most relevant scientific achievements, covering the discoveries in genetic and molecular biology, the endoscopic techniques with guided biopsy, and the metabolic imaging with hybrid PET/CT and MRI/CT. It particularly highlights the emerging strategies in therapy, surgery and mini-invasive surgery as well as loco-regional and systemic treatments, including targeted therapy and/or biological therapies. The second part then explores the management of NENs of various anatomical origins and/or with peculiar biology. It describes the range of the current options and the most relevant results from the clinical trials. This informative book provides valuable insights for all those interested in the management of neuroendocrine neoplasia.

ISBN: 9783030728304

Standard No.: 10.1007/978-3-030-72830-4doiSubjects--Topical Terms:

645497
Endocrinology.

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Neuroendocrine Neoplasia Management = New Approaches for Diagnosis and Treatment /
LDR:04605nam a22003975i 4500 001 1046710
003 DE-He213
005 20211119071040.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030728304 $9 978-3-030-72830-4
024 7 $a 10.1007/978-3-030-72830-4 $2 doi
035 $a 978-3-030-72830-4
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Neuroendocrine Neoplasia Management $h [electronic resource] : $b New Approaches for Diagnosis and Treatment / $c edited by Giordano Beretta, Alfredo Berruti, Emilio Bombardieri, Nicola Fazio, Orlando Goletti.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XIV, 331 p. 52 illus., 48 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Part-1: General. History of Neuroendocrine Neoplasia -- Epidemiology of neuroendocrine neoplasms. Part-2: Diagnosis. New concepts in patholog -- Molecular Biology of Neuroendocrine Tumors -- Circulating biochemical markers of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NENs) -- Advances in diagnostic imaging. Part-3: New Approaches for Treatment. Treatment of NET related symptoms -- New Surgical Strategies -- New approaches in medical therapies -- Loco-regional Therapies of NEN -- Radioreceptor therapy -- NETs of the lung -- Part-4: Treatment of NETs From Different Organ Origin. Gastric Neuroendocrine Tumors -- Treatment of Pancreatic Neurendocrine Tumors -- Treatment of intestinal NETs (including appendix) -- Treatment of NETs from rare origin -- Neuroendocrine Neoplasms with Peculiar Biology and Features: MEN1, MEN2A, MEN2B, MEN4, VHL, NF1. Part-5: NETs with Peculiar Biology and Feature. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasms ( Mi NEN) -- Merkel Cell Carcinoma -- Therapy in poorly differentiated neuroendocrine neoplasms (NEN G3) -- Conclusion:NENs management today looking at the future.
520 $a This book provides the most recent update on the management of neuroendocrine neoplasia (NEN), a term covering all tumors of various organs and/or with a particular histology, including MEN (multiple endocrine neoplasia) related tumors, MiNEN (mixed neuroendocrine-non-neuroendocrine neoplasms), NEC (neuroendocrine carcinoma) and Merkel’s carcinoma. NENs are heterogeneous in their biology, clinical presentation and prognosis, showing a great variability in aggressiveness and therapy response. As a result, their treatment is based on a large spectrum of options. The standard therapies are surgery in early disease, various loco-regional procedures in certain conditions and mostly of a palliative nature in metastatic disease. At present, thanks to our increased understanding of molecular signaling pathways, several pharmacological approaches can be used in patients with advanced NENs. Somatostatin analogs display both anti-tumor effects and symptom control. Novel peptide-radio-receptor treatment (PRRT) is used in patients with well differentiated tumors. The agents targeting angiogenesis and/or PI3K/AKT/mTOR pathway, alone or in combination with analogues, have provided encouraging results in advanced disease. The first part of the book focuses on the history, epidemiology and the most relevant scientific achievements, covering the discoveries in genetic and molecular biology, the endoscopic techniques with guided biopsy, and the metabolic imaging with hybrid PET/CT and MRI/CT. It particularly highlights the emerging strategies in therapy, surgery and mini-invasive surgery as well as loco-regional and systemic treatments, including targeted therapy and/or biological therapies. The second part then explores the management of NENs of various anatomical origins and/or with peculiar biology. It describes the range of the current options and the most relevant results from the clinical trials. This informative book provides valuable insights for all those interested in the management of neuroendocrine neoplasia.
650 2 4 $a Endocrinology. $3 645497
650 2 4 $a Nuclear Medicine. $3 673045
650 1 4 $a Oncology. $3 593951
650 0 $a Surgery. $3 644132
650 0 $a Endocrinology . $3 1254221
650 0 $a Nuclear medicine. $3 673902
650 0 $a Oncology . $3 1253469
700 1 $a Goletti, Orlando. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1350294
700 1 $a Fazio, Nicola. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1350293
700 1 $a Bombardieri, Emilio. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 678341
700 1 $a Berruti, Alfredo. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1350292
700 1 $a Beretta, Giordano. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1350291
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030728298
776 0 8 $i Printed edition: $z 9783030728311
776 0 8 $i Printed edition: $z 9783030728328
856 4 0 $u https://doi.org/10.1007/978-3-030-72830-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)